Ovid Therapeutics
Price & Volume
Stats
See more52W Range | $0.24-$2.01 |
Market Cap | $116M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $6.6M |
Revenue Growth (YoY) | -23.7% |
Gross Profit (12 Mos) | $6.6M |
Diluted EPS | -$0.50 |
News
See moreYahoo Finance • 18 days ago
Ovid Therapeutics GAAP EPS of -$0.17 misses by $0.02, revenue of $0.13M misses by $0.04M
Yahoo Finance • 18 days ago
Ovid Therapeutics Announces Planned Leadership Succession and Reports Business Updates and Third Quarter 2025 Financial Results
Yahoo Finance • 20 days ago
QurAlis Announces Appointment of Manoj Malhotra, M.D., as Chief Medical Officer
Yahoo Finance • 2 months ago
Ovid spikes as Wedbush moves to Outperform on lead asset
About
CEO | Dr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D. |
Address | 441 Ninth Avenue, New York, NY, United States, 10001 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 23 |
